COVID-19 Insights
Omicron-2, the “stealth” variant is becoming prevalent in Denmark and in many Asian countries
Omicron or B.1.1.529, the last “version” of SARS-CoV-2 original strain, was identified almost two months ago. Today, Omicron is going to replace Delta variant prevalence in almost all countries. According to ECDC monitor of Gisaid data, at the moment we write,...
Press
OaCP su Forbes: Un kit per ripartire
Abbiamo raccontato la nostra storia a Forbes che ha deciso di inserirci nel loro speciale Healthcare di luglio. Con tutto il lavoro che stiamo facendo, sia sul fronte oncologico che su quello Covid-19, per essere sempre un passo avanti rispetto ai problemi che...
Events & Awards
OaCP in the top 5 Big Health companies of the China Overseas Talent Innovation and Entrepreneurship Competition
OaCP has won the 4th prize within the Big Health area of expertise of the China Overseas Talent Innovation and Entrepreneurship Competition promoted by Wuhan City. The competition is hosted by China Association for Science and Technology (CAST), People's Government of...
OaCP
First in vivo evidence of escape of SARS-CoV-2 South Africa variant from natural and vaccine-induced sera
Months after the first SARS-CoV-2 variant has been sequenced, many scientific works have largely hypothesized the clinical impact of the mutations, based on in silico experiments. Starting point The role of SARS-CoV-2 mutations has been supposed to impact the immune...
